Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of Two Xylometazoline/Dexpanthenol Nasal Spray Formulations for Nasal Congestion
NCT03439436Phase 3Completed
- Sponsor
- McNeil Laboratories
- Start
- Feb 2018
- Primary completion
- May 2018
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of xylometazoline + dexpanthenol in nasal congestion, sponsored by McNeil Laboratories. Started Feb 2018; status: completed.
02
Drugs
xylometazoline + dexpanthenol
03
Conditions
nasal congestion
Beyond the preview
Go deeper on NCT03439436.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03439436.